ClassID:

96687

C07K5/06043 - CPC Classification

Classification description:

Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms Leu-amino acid

Recent Application in this class:
#1
20250179118
2025-06-05

NOVEL DIPEPTIDE COMPOUNDS AND USES THEREOF

#2
20240092831
2024-03-21

Proteasome Inhibitors

#3
20230242572
2023-08-03

a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#4
20230104690
2023-04-06

MATRIX METALLOPROTEINASE INHIBITORS (MMPIs)

#5
20230002316
2023-01-05

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#6
20220411469
2022-12-29

COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVES

#7
20220089639
2022-03-24

SITE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS

#8
20210395299
2021-12-23

Dipeptide compounds and uses thereof

#9
20210316006
2021-10-14

PYRROLOBENZODIAZEPINE CONJUGATES

#10
20210277056
2021-09-09

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

#11
20210163880
2021-06-03

BIOLOGICALLY ACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES

#12
20210107868
2021-04-15

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#13
20210054025
2021-02-25

Antimicrobial compounds and/or modulators of microbial infections and methods of using the same

#14
20210040039
2021-02-11

NMDA ANTAGONIST PRODRUGS

#15
20200237637
2020-07-30

N-acyldipeptide derivatives and their uses

#16
20200010414
2020-01-09

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#17
20200002382
2020-01-02

Method for manufacturing oxytocin by liquid-phase polypeptide synthesis

#18
20190300570
2019-10-03

Site-specific chemoenzymatic protein modifications

#19
20190233471
2019-08-01

Cytotoxic tubulysin compounds for conjugation

#20
20190152914
2019-05-23

NMDA antagonist prodrugs

#21
20190083631
2019-03-21

Carbonic anhydrase IX inhibitor conjugates and uses thereof

#22
20190062748
2019-02-28

Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo

#23
20180371012
2018-12-27

Quinstatin compounds

#24
20180318425
2018-11-08

Bortezomib conjugates and methods using same

#25
20180305402
2018-10-25

Antimicrobial compounds and/or modulators of microbial infections and methods of using the same

#26
20180303741
2018-10-25

Combination of N-acyldipeptide derivatives and retinol, and methods of use thereof

#27
20180258136
2018-09-13

Branched linker for protein drug conjugates

#28
20180222858
2018-08-09

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#29
20180148475
2018-05-31

Cardiovascular Therapeutics

#30
20180071408
2018-03-15

Cholecystokinin 2 receptor targeted NIR imaging and use thereof

#31
20180037550
2018-02-08

NMDA antagonist prodrugs

#32
20180009845
2018-01-11

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

#33
20170321187
2017-11-09

BIOLOGICALLY ACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES

#34
20170267718
2017-09-21

Tripeptide compound, preparation method therefor, and application thereof

#35
20170260231
2017-09-14

Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof

#36
20170119841
2017-05-04

AMINO ACID SALTS OF UNSATURATED FATTY ACIDS

#37
20170119646
2017-05-04

N-acyldipeptide derivatives and their uses

#38
20170035858
2017-02-09

Myoblast differentiation promoter

#39
20160340386
2016-11-24

Cytotoxic tubulysin compounds for conjugation

#40
20160280647
2016-09-29

NMDA antagonist prodrugs

#41
20160272582
2016-09-22

Compositions and methods for the treatment of hyperglycemia and metabolic syndrome

#42
20160237116
2016-08-18

SITE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS

#43
20160228493
2016-08-11

Aminostatin derivatives for the treatment of arthrosis

#44
20160207958
2016-07-21

Method for producing dipeptide derivative containing disubstituted amino acid residue

#45
20160136230
2016-05-19

Compounds

#46
20160083420
2016-03-24

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#47
20160068788
2016-03-10

Liquid automatic dish washing detergent compositions

#48
20160052966
2016-02-25

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

#49
20160009763
2016-01-14

PEPTIDE MOLECULAR MATERIALS

#50
20150367028
2015-12-24

Amphiphilic linear peptide/peptoid and hydrogel comprising the same

#51
20150353601
2015-12-10

Compounds for enzyme inhibition

#52
20150315234
2015-11-05

MYOBLAST DIFFERENTIATION PROMOTER

#53
20150274737
2015-10-01

Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation

#54
20150250846
2015-09-10

N-acyldipeptide derivatives and their uses

#55
20150203534
2015-07-23

Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors

#56
20150183822
2015-07-02

ANGIOTENSIN-CONVERTING-ENZYME INHIBITING DIPEPTIDE

#57
20150175663
2015-06-25

Process for producing self-assembling peptide derivatives

#58
20150158869
2015-06-11

Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates

#59
20150045573
2015-02-12

Polyconjugates for delivery of RNAi triggers to tumor cells in vivo

#60
20150025021
2015-01-22

Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators

#61
20150017192
2015-01-15

Site-specific chemoenzymatic protein modifications

#62
20140336098
2014-11-13

Stabilized subtilisin composition

#63
20140309401
2014-10-16

DPP-4 inhibitor

#64
20140303080
2014-10-09

N-acyldipeptide derivatives and their uses

#65
20140243274
2014-08-28

Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation

#66
20140187479
2014-07-03

Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism

#67
20130324706
2013-12-05

Branched linker for protein drug conjugates

#68
20130309247
2013-11-21

Dimeric IAP inhibitors

#69
20130303448
2013-11-14

Therapeutic or preventive agent for diabetes

#70
20130244945
2013-09-19

Lissencephaly therapeutic agent

#71
20130072431
2013-03-21

Cardiovascular therapeutics

#72
20130053303
2013-02-28

Compounds for enzyme inhibition

#73
20130041008
2013-02-14

Compounds for enzyme inhibition

#74
20130035297
2013-02-07

Compounds for enzyme inhibition

#75
20130023460
2013-01-24

Amphiphilic linear peptide/peptoid and hydrogel comprising the same

#76
20120302815
2012-11-29

Multi-valent poly-Ubl chain inhibitors and methods of use

#77
20120270813
2012-10-25

Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products

#78
20120253012
2012-10-04

Method for preparing lipopeptide compound

#79
20120214732
2012-08-23

Inhibitors of the trypsin-like site of the proteasome and methods of use thereof

#80
20120122797
2012-05-17

PEPTIDIC COMPOUND AND USE OF SAME

#81
20120115918
2012-05-10

Anti-Viral Compounds

#82
20120108515
2012-05-03

Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation

#83
20120088762
2012-04-12

Compounds for enzyme inhibition

#84
20120022228
2012-01-26

PURIFICATION OF AMPHOTERIC PRODUCTS, OR OF PRODUCTS LIABLE TO BE CONVERTED INTO AMPHOTERIC PRODUCTS

#85
20120021454
2012-01-26

Rapid FRET-based diagnosis of bacterial pathogens

#86
20110312965
2011-12-22

Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties

#87
20110306560
2011-12-15

Boronic ester and acid compounds, synthesis and uses

#88
20110294719
2011-12-01

Dipeptoid prodrugs and the use thereof

#89
20110275524
2011-11-10

METHODS AND SYSTEMS TO DETECT AN ACTIVE PROTEASE IN A SAMPLE

#90
20110183413
2011-07-28

Biologically active C-terminal arginine-containing peptides

#91
20110071075
2011-03-24

PROMOTER FOR BICARBONATE SECRETION IN GASTROINTESTINAL TRACT

#92
20110053858
2011-03-03

Heterocyclic peptide ketoamides

#93
20110045530
2011-02-24

ENZYMATIC CONJUGATION OF BIOACTIVE MOIETIES

#94
20100311690
2010-12-09

BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM

#95
20100304363
2010-12-02

PEPTIDE COMPOUNDS FOR DETECTING OR INHIBITING SARS CORONAVIRUS AND APPLICATION THEREOF

#96
20100279334
2010-11-04

CYCLODIPEPTIDE SYNTHASES (CDSS) AND THEIR USE IN THE SYNTHESIS OF LINEAR DIPEPTIDES

#97
20100267634
2010-10-21

Anti-viral compounds

#98
20100266503
2010-10-21

Breast Cancer Methods, Medicaments and Agents

#99
20100210564
2010-08-19

DRUG OR FOOD CONTAINING A PEPTIDE

#100
20100144649
2010-06-10

Compounds for enzyme inhibition

#101
20100144648
2010-06-10

Compounds for enzyme inhibition

#102
20100105864
2010-04-29

PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIARRHEA

#103
20090286763
2009-11-19

AMINO ACID DERIVED PRODRUGS OF PROPOFOL, COMPOSITIONS AND USES THEREOF

#104
20090270618
2009-10-29

Phosphonyl ester conjugates as prodrugs

#105
20090247731
2009-10-01

Boronic ester and acid compounds, synthesis and uses

#106
20090239809
2009-09-24

Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products

#107
20090227522
2009-09-10

Targeted delivery of pharmaceutical compounds

#108
20090143248
2009-06-04

Biologically active C-terminal arginine-containing peptides

#109
20090012007
2009-01-08

Mimetic peptides and the use thereof in the form of 20S, 26S and immunoproteasome inhibitors

#110
20080300191
2008-12-04

Protease inhibitors for coronaviruses and SARS-CoV and the use thereof

#111
20080132678
2008-06-05

Boronic ester and acid compounds, synthesis and uses

#112
20080112946
2008-05-15

Catalytically active recombinant memapsin and methods of use thereof

#113
20080027060
2008-01-31

DIPEPTIDE NITRILES

#114
20080021196
2008-01-24

Inhibitors of Memapsin 2 and use thereof

#115
20070293465
2007-12-20

Compounds for enzyme inhibition

#116
20070282100
2007-12-06

Boronic ester and acid compounds, synthesis and uses

#117
20070269898
2007-11-22

Amino Acid Sequences Essential to Neuron Specific Gene Expression

#118
20070243581
2007-10-18

Process for Producing Dipeptides

#119
20070105785
2007-05-10

Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators

#120
20070037863
2007-02-15

Dipeptide phenyl ethers

#121
20070004642
2007-01-04

Oxadiazole derivatives and drugs containing these derivatives as the active ingredient

#122
20070004636
2007-01-04

Method of degrading transcriptional factors of saccharometabolism-associated gene, method for inhibiting the degradation, and agent for inhibiting degradation and degradation inhibitor

#123
20060241057
2006-10-26

Peptidyl allyl sulfones

#124
20060235220
2006-10-19

Dipeptide nitriles

#125
20060183732
2006-08-17

Lactams and uses thereof

#126
20060172952
2006-08-03

Aza-peptide epoxides

#127
20060166893
2006-07-27

2-hydroxytetrahydrofuran derivatives and use thereof as medicaments

#128
20060134130
2006-06-22

Oral drug delivery compositions and methods

#129
20060122390
2006-06-08

Boronic ester and acid compounds, synthesis and uses

#130
20060111276
2006-05-25

Cidofovir peptide conjugates as prodrugs

#131
20060100160
2006-05-11

Amino acid derived prodrugs of propofol, compositions and uses thereof

#132
20060036073
2006-02-16

Neurotrophic and neuroprotective peptides

#133
20050255138
2005-11-17

Active agent transport systems

#134
20050245511
2005-11-03

Novel compounds that inhibit tryptase activity

#135
20050222045
2005-10-06

Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments

#136
20050113421
2005-05-26

Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating non-inflammatory gastrointestinal tract disorders

#137
20050101764
2005-05-12

Process for the preparation of peptides

#138
20050095248
2005-05-05

Suppression of immune response via inhibition of cathepsin S

#139
20050080010
2005-04-14

Suppression of immune response via inhibition of cathepsin S

#140
20050075293
2005-04-07

Dipeptide phenyl ethers

#141
20050075281
2005-04-07

Acylated nonadepsipeptides

#142
20050059599
2005-03-17

Elastin peptide analogs and uses thereof

#143
20050026835
2005-02-03

Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators

#144
14726020
2017-05-16

Dual-action EP4 agonist—bisphosphonate conjugates and uses thereof